You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Clinical Trials Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
Correspondence Antihypertensive Medications Influence the Rate of Conversion From Mild Cognitive Impairment to Alzheimer Disease
Luca Rozzini; Barbara Vicini Chilovi; Marco Trabucchi; Alessandro Padovani
Arch Neurol 2008; 65: 993-994.
[Extract][Full text][PDF]
Correspondence Antihypertensive Medications Influence the Rate of Conversion From Mild Cognitive Impairment to Alzheimer Disease—Reply
Christiane Reitz; Richard Mayeux; José A. Luchsinger
Arch Neurol 2008; 65: 995.
[Extract][Full text]
Original Contributions Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Chitra Krishnan; Adam I. Kaplin; Robert A. Brodsky; Daniel B. Drachman; Richard J. Jones; Dzung L. Pham; Nancy D. Richert; Carlos A. Pardo; David M. Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C. McArthur; Avindra Nath; Benjamin M. Greenberg; Peter A. Calabresi; Douglas A. Kerr
Arch Neurol 65.8.noc80042.
[Abstract][Full text][]
Neurological Reviews Common Pathophysiologic Mechanisms in Migraine and Epilepsy